Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS By Investing.com

© Reuters. After-Hours Stock Movers: Spectrum Pharmaceuticals (NASDAQ:) 28% LOWER; The FDA’s Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations. The committee voted 9-4 that the current benefits of poziotinib did … Read more

Govt sets up panel to suggest measures for more private equity investments

New Delhi, Sep 13 (IANS) The government has set up an expert committee, headed by former SEBI Chairman Meleveetil Damodaran, to suggest appropriate measures to address regulatory and other issues, so that investments by venture capital and private equity investors can be scaled up. The six-member committee has been set up in accordance with the … Read more

Amylyx Surges on FDA Panel Backing, American Eagle Falls Post EPS By Investing.com

© Reuters. Pre-Open Stock Movers: Amylyx Pharmaceuticals Inc (NASDAQ:) 75% HIGHER; announced today that the U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) voted (7 yes votes and 2 no votes) that the available evidence of effectiveness is sufficient to support approval of AMX0035 (sodium phenylbutyrate and taurursodiol … Read more